-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&DPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
2004
June 3: Beijing NORTHLAND Biotechnology Co., Ltd. was registered and established in the Zhongguancun Biomedical Park.
November 1: Beijing NORTHLAND Biotechnology Co., Ltd. successfully passed the certification as a “High-Tech Enterprise” and received the “High-Tech Enterprise Certification” issued by the Beijing Municipal Science and Technology Commission.
November 6: A delegation of three members—Mr. Daeyon Kang, President of South Korea’s ViroMed Company, Dr. Jong-Mook Kim, and Dr. Sujeong Kim—visited the company for an academic exchange. Both sides reached a constructive consensus on the results of various experimental studies related to their collaborative project.
December 1: Mr. Akira Hirose, President of Japan’s ORIX Capital, and Mr. Hideya Sakurai visited our company for a tour and exchange. During the visit, both sides exchanged views and gained mutual understanding on new drug development projects.
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005